Axcelis to Showcase Advanced Ion Implant Solutions at SEMICON Japan 2025

BEVERLY, Mass. , Dec. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today its participation in SEMICON Japan 2025, taking place December 17–19 at Tokyo Big Sight in Tokyo, Japan.

PRNewsWire • Dec 10, 2025

Axcelis Technologies: Ready For A Gradual Rerating (Rating Upgrade)

Axcelis Technologies is upgraded to BUY after Q3FY25 revenue beat and signs of business stabilization. ACLS announced an all-stock merger with Veeco to diversify end markets and reinforce non-China presence, pending regulatory approval. Free cash flow remains robust at ~$120m annually, yielding 4.5% on market cap, supporting attractive valuation.

Seeking Alpha • Dec 10, 2025

Axcelis Technologies (ACLS) Recently Broke Out Above the 50-Day Moving Average

From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

Zacks Investment Research • Nov 11, 2025

Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Zacks Investment Research • Nov 10, 2025

Axcelis Announces Participation in Upcoming Investor Conferences

BEVERLY, Mass. , Nov. 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Wells Fargo 9th Annual TMT Summit on November 18, 2025 at the Terranea Resort, Rancho Palos Verdes, CA.

PRNewsWire • Nov 6, 2025

All You Need to Know About Axcelis (ACLS) Rating Upgrade to Buy

Axcelis (ACLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Nov 6, 2025

Axcelis Technologies, Inc. (ACLS) Q3 2025 Earnings Call Transcript

Axcelis Technologies, Inc. ( ACLS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy Russell Low - CEO, President & Director James Coogan - Executive VP & CFO Conference Call Participants Jonathan Dorsheimer - William Blair & Company L.L.C., Research Division Craig Ellis - B.

Seeking Alpha • Nov 4, 2025

Axcelis Announces Financial Results for Third Quarter 2025

Q3 Highlights: Revenue of $213.6 million GAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8% GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2% GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21 BEVERLY, Mass. , Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2025.

PRNewsWire • Nov 4, 2025

Axcelis Technologies (ACLS) Q3 Earnings and Revenues Surpass Estimates

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.49 per share a year ago.

Zacks Investment Research • Nov 4, 2025

Investors Are Looking to Axcelis as the Next Wave of Chip Growth Builds

Bought 91,788 shares of Axcelis Technologies (NASDAQ: ACLS); estimated at ~$7.39 million based on the average price in the third quarter of 2025 Transaction value represents 0.24% of reportable AUM Post-trade stake: 1,610,332 shares valued at $157.23 million Axcelis Technologies is now the fund's 1st-largest holding, at 5.1% of AUM

The Motley Fool • Oct 31, 2025